Lindocaine Hydrochloride Monohydrate Articles
Anesiva shareholders agree to Arcion takeover
8 December 2009
Anesiva cuts workforce by 20%
15 September 2008
FDA accepts Anesiva's Zingo sNDA
26 May 2008
Anesiva expands Zingo deal with Sigma-Tau
5 May 2008
Alta Partners invests $25M in Anesiva
24 December 2007
Less IV procedure pain with Anesiva's Zingo
5 November 2007
Anesiva and Sagent in deal to co-promote Zingo to US hospitals
22 October 2007
Anesiva's Zingo cleared by FDA
3 September 2007
Anesiva halts drug candidate 1207 development
22 January 2007
Anesiva files Zingo NDA with FDA
4 December 2006
Showing 1-11 of 11 articles
- 1
- Encouraging results with Sangamo's SB-728-T in HIV treatment
- Boehringer Ingelheim transitions to propellant-free Combivent Respimat; names new BMD member
- Bristol-Myers' data on Yervoy and nivolumab causes a stir
- Sanofi prepares for regulatory filing of MF candidate on positive JAKARTA study results
- Neovacs moving forward in rheumatoid arthritis, say analysts
